US FDA Changing View Of Citizen Petition Response Time, Could Eliminate Serial Refiling
By aligning petition filing deadlines with user fee goals, agency could discourage petitions that need response within 150 days, potentially ending non-substantive response practice.
You may also be interested in...
Former US FDA commissioner Scott Gottlieb doesn't "want to give too much away," but expresses skepticism about Trump administration's ability to implement its international price index proposal, noting there are ways for brand companies to game the system.
US FDA can encourage and increase competition, but cannot force generic companies to enter markets deemed unprofitable, CDER director says.
FDA worries about diverting resources to respond to 505(q) petitions, despite receiving lowest number in fiscal year 2015 since it began tracking requests.